Drug · DIN 02363445
OZURDEX
IMPLANT IN SINGLE-USE APPLICATOR. PRESERVATIVE-FREE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since March 11, 2024; first marketed June 2, 2011.
- Drug Identification Number (DIN)
- 02363445
- Company (DIN owner)
- AbbVie CorporationSaint-Laurent, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Implant
- Route
- Intravitreal
- Therapeutic class (ATC)
- Dexamethasone S01BA01
- Class
- Human
- Record last updated
- May 19, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DEXAMETHASONE | 0.7 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 29, 2022: NOC 28848New Drug Submission (NDS) · Administrative: Merger/Buy-out
- February 10, 2011: NOC 12057New Drug Submission (NDS)